Home/Investors/Section 32

Section 32

Biotech Investor · 8 portfolio companies

Portfolio

8

Focus Areas

12

Top Stage

platform

Investment Focus

Oncology Immunology Infectious Disease Autoimmune Diseases Alzheimer's Disease Parkinson's Disease Cardiometabolic Disease Neurology Genetics & Genomics Diagnostics Neuroscience Psychiatry

Portfolio Companies

Company	Stage	Valuation	Focus
Alloy Therapeutics	platform	—	Oncology, Immunology
CellThera AI	platform	—	Oncology, Autoimmune Diseases
Rome Therapeutics	preclinical	—	Oncology, Immunology
Manifold Bio	Pre-clinical	—	Alzheimer's Disease, Parkinson's Disease
Nucleai	—	—	Oncology
BioGen AI	platform	—	Oncology, Neurology
GenomeAI	platform	—	Genetics & Genomics, Diagnostics
NeuroTech AI	platform	—	Neuroscience, Psychiatry

Frequent Co-Investors

Andreessen Horowitz5 shared ARCH Venture Partners2 shared GV2 shared Mubadala Capital1 shared 8VC1 shared Bristol Myers Squibb1 shared Sanofi Ventures1 shared Khosla Ventures1 shared